An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors

被引:24
|
作者
Patel, Ami V. [1 ]
Chaney, Katherine E. [1 ]
Choi, Kwangmin [1 ]
Largaespada, David A. [3 ]
Kumar, Ashish R. [2 ]
Ratner, Nancy [1 ]
机构
[1] Univ Cincinnati, Cincinnati Childrens Hosp, Div Expt Hematol & Canc Biol, Dept Pediat, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Cincinnati Childrens Hosp, Div Bone Marrow Transplantat & Immune Deficiency, Dept Pediat, Cincinnati, OH 45229 USA
[3] Univ Minnesota, Dept Pediat, Masonic Canc Ctr, Minneapolis, MN 55455 USA
来源
EBIOMEDICINE | 2016年 / 9卷
关键词
MPNST; MEIS1; ID1; RNAi; p27(Kip); G0/G1; arrest; Sarcoma; NEUROFIBROMATOSIS TYPE-1 GENE; SELF-RENEWAL; STEM-CELLS; RNA INTERFERENCE; SCHWANN-CELLS; CANCER; LEUKEMIA; TRANSFORMATION; TUMORIGENESIS; EXPRESSION;
D O I
10.1016/j.ebiom.2016.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant peripheral nerve sheath tumors (MPNST) are rare soft tissue sarcomas that are a major source of mortality in neurofibromatosis type 1 (NF1) patients. To identify MPNST driver genes, we performed a lentiviral short hairpin (sh) RNA screen, targeting all 130 genes up-regulated in neurofibroma and MPNSTs versus normal human nerve Schwann cells. NF1 mutant cells show activation of RAS/MAPK signaling, so a counter-screen in RAS mutant carcinoma cells was performed to exclude common RAS-pathway driven genes. We identified 7 genes specific for survival of MPSNT cells, including MEIS1. MEIS1 was frequently amplified or hypomethylated in human MPSNTs, correlating with elevated MEIS1 gene expression. In MPNST cells and in a genetically engineered mouse model, MEIS1 expression in developing nerve glial cells was necessary for MPNST growth. Mechanistically, MEIS1 drives MPNST cell growth via the transcription factor ID1, thereby suppressing expression of the cell cycle inhibitor p27(Kip) and maintaining cell survival. (C) 2016 Published by Elsevier B.V.
引用
收藏
页码:110 / 119
页数:10
相关论文
共 50 条
  • [41] Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors
    Upadhyaya, Meena
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 937 - 951
  • [42] Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53
    Holand, Maren
    Kolberg, Matthias
    Danielsen, Stine Aske
    Bjerkehagen, Bodil
    Eilertsen, Ina A.
    Hektoen, Merete
    Mandahl, Nils
    van den Berg, Eva
    Smeland, Sigbjorn
    Mertens, Fredrik
    Hall, Kirsten Sundby
    Picci, Piero
    Sveen, Anita
    Lothe, Ragnhild A.
    MODERN PATHOLOGY, 2018, 31 (11) : 1694 - 1707
  • [43] Prognostic Significance of Immunohistochemical Markers and Genetic Alterations in Malignant Peripheral Nerve Sheath Tumors: A Systematic Review
    Martin, Enrico
    Acem, Ibtissam
    Grunhagen, Dirk J.
    Bovee, Judith V. M. G.
    Verhoef, Cornelis
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Recurrent SMARCB1 Inactivation in Epithelioid Malignant Peripheral Nerve Sheath Tumors
    Schaefer, Inga-Marie
    Dong, Fei
    Garcia, Elizabeth P.
    Fletcher, Christopher D. M.
    Jo, Vickie Y.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (06) : 835 - 843
  • [45] Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors
    Amirnasr, Azadeh
    Verdijk, Robert M.
    van Kuijk, Patricia F.
    Kartal, Pinar
    Vriends, Anne L. M.
    French, Pim J.
    van Royen, Martin E.
    Taal, Walter
    Sleijfer, Stefan
    Wiemer, Erik A. C.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [46] BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors
    Hirbe, Angela C.
    Pekmezci, Melike
    Dahiya, Sonika
    Apicelli, Anthony J.
    Van Tine, Brian A.
    Perry, Arie
    Gutmann, David H.
    NEURO-ONCOLOGY, 2014, 16 (03) : 466 - 467
  • [47] Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine
    Castellsague, Joan
    Gel, Bernat
    Fernandez-Rodriguez, Juana
    Llatjos, Roger
    Blanco, Ignacio
    Benavente, Yolanda
    Perez-Sidelnikova, Diana
    Garcia-del Muro, Javier
    Vinals, Joan Maria
    Vidal, August
    Valdes-Mas, Rafael
    Terribas, Ernest
    Lopez-Doriga, Adriana
    Pujana, Miguel Angel
    Capella, Gabriel
    Puente, Xose S.
    Serra, Eduard
    Villanueva, Alberto
    Lazaro, Conxi
    EMBO MOLECULAR MEDICINE, 2015, 7 (05) : 608 - 627
  • [48] Malignant peripheral nerve sheath tumour (MPNST)
    Czarnecka, Anna M.
    Sobczuk, Pawel
    Zdzienicki, Marcin
    Spalek, Mateusz
    Rutkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (06): : 364 - 376
  • [49] Intracranial Malignant Peripheral Nerve Sheath Tumors Not Associated with a Cranial Nerve: Systematic Review and Illustrative Case
    Mackel, Charles E.
    Medeiros, Isabela
    Moore, Brian E.
    Zhao, Qing
    Jha, Ribhu
    WORLD NEUROSURGERY, 2021, 156 : 76 - 91
  • [50] Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)
    Alaggio, Rita
    Turrini, Riccardo
    Boldrin, Daniela
    Merlo, Anna
    Gambini, Claudio
    Ferrari, Andrea
    Dall'Igna, Patrizia
    Coffin, Cheryl M.
    Martines, Annalisa
    Bonaldi, Laura
    De Salvo, Gian Luca
    Zanovello, Paola
    Rosato, Antonio
    PLOS ONE, 2013, 8 (11):